H. Friccius-Quecke

Treatment of non-small cell lung cancer patients with the trifunctional monoclonal antibody catumaxomab (anti-EpCAM × anti-CD3): a phase I study

Martin Sebastian, Bernward Passlick, H. Friccius-Quecke et al. · Cancer Immunology Immunotherapy · 2007 · 98 citations · Full text

Medicine, Immunology, Oncology +16

Treatment of Malignant Pleural Effusion With the Trifunctional Antibody Catumaxomab (Removab) (Anti-EpCAM×Anti-CD3)

Martin Sebastian, Philipp Kiewe, Wolfgang Schuette et al. · Journal of Immunotherapy · 2009 · 66 citations

Life Sciences, Immunology, Pharmacology +17

Catumaxomab for the Treatment of Malignant Ascites in Patients With Chemotherapy-Refractory Ovarian Cancer

Jonathan S. Berek, Robert P. Edwards, Lynn P. Parker et al. · International Journal of Gynecological Cancer · 2014 · 50 citations

Medicine, Oncology, Pharmacotherapy +14

Catumaxomab with and without prednisolone premedication for the treatment of malignant ascites due to epithelial cancer: results of the randomised phase IIIb CASIMAS study

Jalid Sehouli, Klaus Pietzner, Pauline Wimberger et al. · Medical Oncology · 2014 · 17 citations

Medicine, Oncology, Pharmacotherapy +9

Re-challenge with catumaxomab in patients with malignant ascites: results from the SECIMAS study

Klaus Pietzner, Ignace Vergote, Armando Santoro et al. · Medical Oncology · 2014 · 11 citations

Medicine, Oncology, Pathology +6